Brief: Structure Therapeutics Inc. Q3 Net Income USD -65.712 Million
06/11/2025 21:01
Nov 06 (Reuters) - Structure Therapeutics Inc. Q3 operating expenses USD 73.787 million. Q3 income from operations USD -73.787 million
Recent news on Structure Therapeutics
See all newsFactbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Factbox: Weight-loss drug developers line up to tap lucrative market as competition heats up
Structure falls as investors await more obesity trial data, says Jefferies